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Abstract
Background: Mindfulness-based approaches for adults are effective at enhancing mental health, but few controlled
trials have evaluated their effectiveness or cost-effectiveness for young people. The primary aim of this trial is to
evaluate the effectiveness and cost-effectiveness of a mindfulness training (MT) programme to enhance mental
health, wellbeing and social-emotional behavioural functioning in adolescence.
Methods/design: To address this aim, the design will be a superiority, cluster randomised controlled, parallel-group
trial in which schools offering social and emotional provision in line with good practice (Formby et al., Personal,
Social, Health and Economic (PSHE) Education: A mapping study of the prevalent models of delivery and their
effectiveness, 2010; OFSTED, Not Yet Good Enough: Personal, Social, Health and Economic Education in schools,
2013) will be randomised to either continue this provision (control) or include MT in this provision (intervention).
The study will recruit and randomise 76 schools (clusters) and 5700 school students aged 12 to 14 years, followed
up for 2 years.
Discussion: The study will contribute to establishing if MT is an effective and cost-effective approach to promoting
mental health in adolescence.
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Background
In the UK, the annual economic cost of mental health
problems has been estimated at £105 billion [1, 2]. Men-
tal health problems commonly have their first onset in
adolescence, which is a period of heightened vulnerabil-
ity associated with reduced attentional, emotional and
behavioural regulation in the face of growing demands
[3, 4]. In fact, 50% of adults with psychiatric disorders
experience clinically impairing psychopathology before
age 15 years, and 75% by age 24 years [5].
Of all mental health disorders that emerge during ado-
lescence, depression is the one with the largest impact
on health throughout the lifespan in terms of Years Lost
to Disability [6]. Among adults with recurrent depres-
sion, the earlier their depression first develops, the more
severe its subsequent clinical course [7]. Onset in child-
hood or adolescence is associated with greater impair-
ments in social and occupational functioning and
reduced quality of life, with adolescent depression asso-
ciated with poor academic performance, family and so-
cial difficulties, physical ill-health, suicide attempts and
completed suicide [8–11]. Such increased severity of
early onset depression is also reflected in the fact that
within child and adolescent samples, depression is often
comorbid with other disorders; more than a third of
these young people have a disruptive behavioural dis-
order, anxiety disorder or both [12, 13]. It is, therefore,
vital that effective interventions are developed to tackle
these vulnerability processes and to target those inter-
ventions during this critical window of adolescence.
There have been many calls to develop programmes
for adolescents to reduce risk of mental ill-health,
promote wellbeing and develop life skills across the
spectrum of wellbeing and functioning [14, 15]. Be-
cause of their broad reach and central role in the
lives of children and families, schools are seen as the
primary setting where such efforts should be focussed
[16]. However, there are many challenges to imple-
menting such school-based programmes. In particular,
targeted interventions, selectively offered only to ado-
lescents deemed at risk of later mental health prob-
lems, face substantial costs associated with screening
and can be stigmatising. Critically, they also miss
those currently deemed at lower risk, but whose risk
profile changes later.
As an alternative, recent systematic reviews and gov-
ernmental reports suggest that school-based universal
approaches, offered to the whole population, have the
most potential to promote the mental health of young
people [17, 18, 19]. However, the current research high-
lights that for such universal interventions to succeed,
several key pragmatic and theoretical issues need to be
considered [20]. At the pragmatic level, many pro-
grammes do not consider fully how best to support
teachers to deliver the intervention competently [18] or
try to implement programmes without due attention to
known implementation facilitators and barriers [21].
Even if these pragmatic concerns are resolved, more
fundamental theoretical issues still remain. Many exist-
ing universal interventions, aimed at reducing the risk of
depression in young people, are based on theoretical
models originally developed to address established psy-
chopathology (e.g. cognitive theory and therapy) – that
is, they are designed to be used when people are unwell.
They therefore lack relevance, both for low-risk adoles-
cents and for those who are at high risk, but not cur-
rently showing symptoms. To illustrate, a recent UK,
fully powered, large-scale, cluster randomised controlled
trial (RCT) based on cognitive behavioural therapy
(CBT) principles had good reach, but low acceptability
[22]. The study found that the intervention had no effect
compared to usual school provision or attention control
conditions [22], consistent with other recent well-
designed RCTs [14, 23, 24].
This suggests that the theoretical basis for an effective
universal intervention needs to focus on those critical
psychological mechanisms that are universally relevant
for the whole spectrum of mental health, from risk at
one end, through resilience, to flourishing at the other
end. The proposed trial is grounded in such a framework
and evaluates a method of mental training (mindfulness)
to modify these core mechanisms which can be used by
all young people.
Our key theoretical premise is that mental health and
wellbeing are compromised when there is diminished
ability to effectively harness top-down executive control
to pursue goals and plans when faced with salient, com-
peting distraction from bottom-up processes [25–29].
The significance of this premise is that this proposed
central cognitive mechanism applies not only to those at
risk, but also across the wellbeing spectrum.
For individuals at risk of internalising problems, such
as depression and anxiety, deficits in executive control
manifest as difficulty in regulating cognition, affect and
behaviour in the face of distracting, intrusive, negative
thoughts and feelings [30–36]. For those at risk of exter-
nalising problems (conduct and antisocial/disruptive be-
haviour), deficits in executive control manifest as
impaired impulse regulation, a problem that is associ-
ated with long-term impairments across multiple do-
mains of functioning [37, 38].
For those who are resilient or flourishing, executive
control enables the effective deployment of attention in
the face of relatively innocuous, but habitual, patterns of
thought (e.g. rumination) that can distract from current
plans, exacerbate everyday stresses (affecting test-taking,
sports performance and sleep) and undermine wellbeing
[39, 40]. In sum, the hypothesis is that enhancing
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executive control in the face of these diverse challenges
will both reduce risk for vulnerable adolescents as well
as promote flourishing among those who are already
resilient.
Our theoretical framework points us towards a train-
ing method that focusses on modifying key executive
processes, instead of focussing on reducing pathology-
specific negative patterns of thinking and behaviour. Our
programme aims to examine one such method, mindful-
ness training (MT) which is specifically designed to ad-
dress such processes [29] and can be used when people
are well [41, 42].
MT involves systematic practice in focussing attention
in a sustained and intentional way. It augments the abil-
ity to exercise top-down executive control in the face of
motivationally compelling distractions [43–46]. It also
reduces intrusive thoughts and ensuing ruminative re-
sponses [47–50] and behavioural impulses [51]. MT has
been developed as a preventive intervention for those
who already have enduring mental health problems. For
example, mindfulness-based cognitive therapy (MBCT)
was developed for people with a depression history but
who are currently well, to prevent future depressive re-
lapse [52]. The evidence base for its effectiveness and
cost-effectiveness is growing [53–55], and it is now rec-
ommended by National Institute for Health and Care
Excellence (NICE) (2009) as a first-line psychosocial
treatment for secondary prevention of recurrent depres-
sion. Early studies suggest that MBCT’s preventive effect
was greatest in those who had experienced three or
more prior episodes. However, we now know that the
number of episodes predicts good response because it is
a marker for those with greater vulnerability due to pre-
adult onset of depression and early adversity [56]. The
effects of MT are not, however, confined to vulnerable
groups. It has been found to have beneficial effects, via
executive function changes, in nonclinical populations
[47, 57]. This suggests that MT is not only acceptable to
nonclinical populations, but also has huge promise for
primary prevention of depression because it enables
intervention in early adolescence, the point at which
such vulnerability first emerges.
The research question is:
‘Does MT have the potential in adolescents to shift
the population away from psychopathology and
towards improved mental health and wellbeing by
addressing key processes of mental regulation and
executive control that operate across the spectrum of
risk/resilience?’
The acceptability and feasibility of MT in young
people appears promising [58–62]. However, there are
many unanswered questions about its ability to
prevent future depression and other mental health
problems in adolescence, its mechanisms of action
and what moderates its effectiveness. Also, there are
no robust RCTs – grounded in theory and using an
adequate follow-up period – that have evaluated the
benefits of MT across the whole spectrum of risk/re-
silience in adolescence [60].
A prototype of a school-based MT programme has
been developed by classroom teachers to teach mindful-
ness skills in a UK context as an integral part of the
school curriculum [63]. This MT programme was
piloted against matched comparison schools, including
some schools with higher than average deprivation
scores and more children with special needs. Not only
was MT acceptable to secondary school children and
teachers, but compared with normal school provision of
social-emotional teaching, MT also reduced children’s
depressive symptoms and increased their wellbeing. This
was maintained at 3-month follow-up (adjusted mean
differences: depression, (Center for Epidemiologic Stud-
ies for Depression Scale; CES-D [64]), −1.4, 95% CI −2.3
to −0.05, p = 0.005; wellbeing, (Warwick-Edinburgh
Mental Wellbeing Scale; WEMWBS [65]), 3.0, 95% CI
0.0 to 6.0, p = 0.05). Effects on wellbeing and depressive
symptoms were most marked at times of highest stress,
and greater use of mindfulness skills was associated with
stronger effects [66].
Provisional evidence from this nonrandomised feasibil-
ity trial is encouraging. Moreover, interventions that are
designed with implementation in mind are likely to
prove more acceptable [21, 67]. When adapted appropri-
ately, MT is acceptable in more deprived and culturally
diverse settings [68] and among young people with at-
tention and conduct disorders [69]. Importantly, prelim-
inary evidence suggests that MT in schools benefits not
only young people, but also shows promise in enhancing
teachers’ self-efficacy and wellbeing [58, 70, 71]. There is
a need for an adequately powered RCT – that uses vali-
dated outcomes assessed over meaningful time frames –
of a theory-based and thoughtfully implemented MT
programme. Moreover, as the MT is delivered as a uni-
versal school intervention, a cluster RCT is required
where schools are the units of allocation.
This study protocol describes a cluster RCT designed to
evaluate the effectiveness and cost-effectiveness of includ-
ing a MT programme within provision of social-emotional
teaching compared with social-emotional TAU for young
people aged 12–14 years within secondary schools. This
protocol has been informed by learning from two feasibil-
ity studies [66, 72] and several large-scale school-based
studies [12, 16, 67, 73–77]. The protocol is written in con-
junction with the Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) guidance for
protocols [78], see Additional file 1. The trial will comply
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with the Ottawa Statement on the ethical conduct and de-
sign of cluster RCTs [79] and the findings will be reported
in accordance with the 2010 Consolidated Standards of
Reporting Trials (CONSORT) Statement [80] (including
its extension to cluster RCTs [81]).
The primary aim is to determine the effectiveness and
cost-effectiveness of the MT programme on three co-
primary self-report outcomes at 2-year follow-up, mea-
sured at the level of the individual young person:
1. Risk for depression,
2. Socioemotional and behavioural functioning, and
3. Wellbeing.
Broader secondary individual-level outcomes for stu-
dents will include executive functioning, drug use, peer
relationships, anxiety, attainment and mindfulness skills.
Teachers will also rate the pupils on socioemotional and
behavioural functioning.
For teachers, secondary outcomes will include stress,
anxiety, depression, burnout and classroom mindfulness.
Secondary school-level outcomes will include school
ecology and climate.
Methods/design
Study design
The design will be a superiority, cluster randomised con-
trolled, parallel-group trial in which inclusion of the MT
programme within school social-emotional teaching
provision will be compared with provision of school
social-emotional teaching as usual (teaching as usual,
TAU), in 76 schools (clusters); 6840 school students
(ages 12–14 years) will be approached to recruit 5700
(Fig. 1, CONSORT diagram). To ensure that baseline
measures are collected for all clusters (i.e. schools) prior
to randomisation pupils (approximately 25,000) will be
enrolled into the study to provide baseline assessments
(primary measures only), usually across both years 7 and
8. Only a subset of these pupils, who are members of
classes subsequently selected to participate in the full
trial, will move on to become full trial participants the
following year. The reason for conducting baseline as-
sessments with all pupils in the relevant year groups is
that assignment of pupils to class groups varies in some
schools from year to year. It is not, therefore, possible to
randomly select and baseline pupils from a subset of
classes at the outset to the trial and be confident that
these pupils will still be taught together in the following,
intervention, year. Conducting baseline assessments with
all pupils ensures that these data are available for all pu-
pils who might conceivably be grouped together in the
year that the intervention will be delivered.
The definition of trial participants will be those who
provide data at the baseline assessment and are mem-
bers of one of the classes subsequently selected for con-
tinued trial participation. Those pupils who do not
Fig. 1 Consolidated Standards for Reporting Trials (CONSORT) diagram: participant flow, showing recruitment, training, intervention and
assessment schedule
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provide baseline assessment data (for example, due to
absence) but are subsequently present in selected trial
classes will not be included as trial participants.
A two-arm trial as opposed to a three-arm trial is
employed for several reasons. First, the research ques-
tion addresses the key remaining uncertainty: does MT
add value over current UK good practice in relation to
social-emotional teaching? Second, MT’s mechanisms of
action, relative to an active control condition, are exam-
ined through a separate programme of work. Third, our
experience is that cluster RCTs on this scale are most
likely to be a rigorous test of effectiveness/cost-effective-
ness when they are as simple as possible and when
school heads, teachers and pupils perceive there to be
equipoise between the two arms.
Setting
Secondary schools chosen to be recruited are broadly
representative of those UK secondary schools which
offer social-emotional teaching in line with good practice
guidance and are open to having the content and quality
of their provision monitored.
Participants and eligibility
A sample of mainstream UK secondary schools will be
recruited that is representative of such schools, both
with respect to the population served (on key variables
such as deprivation, operationalised as eligibility for free
school meals) and the type of school (e.g. selective/non-
selective, urban/rural, large/small, mixed/single-gender,
state maintained/independent). We will not include spe-
cial schools or alternative settings where education is
provided. Only schools that offer social-emotional teach-
ing in line with good practice will be eligible for partici-
pation, determined using a measure designed for this
study to benchmark against key dimensions. Schools
must also be willing to commit to the My Resilience in
Adolescence (MYRIAD) study, including the teacher
training required in schools randomised to MT and
teacher and pupil assessments and follow-ups. To miti-
gate risk to implementation, schools that are rated by
national inspectors on measures of quality as ‘inad-
equate’, or where there is no substantive head, will be
excluded.
Within schools, participating teachers will be quali-
fied/experienced teachers who have given their consent
to participate in the research and to complete the train-
ing in the delivery of the MT programme and subse-
quently to deliver the MT programme, should their
school be randomised to the MT arm of the trial. Should
the school be randomised to the TAU arm these teachers
will be assessed as ‘controls’. They will normally be on
substantive teaching contracts to increase the likelihood
that they will remain teaching within the school during
the research period.
Recruitment
Recruitment of schools, teachers and pupils will occur in
two recruitment cohorts with each new cohort starting
at the beginning of a school year. For the first cohort the
aim will be to enrol a relatively small number of schools
(approximately 13), with the remainder recruited in the
following cohort. The first cohort will serve to ensure
that all the protocols (e.g. recruitment) are fit for pur-
pose before proceeding to the second cohort. A variety
of recruitment strategies will be employed; for example:
newspaper articles, email or telephone calls with local
authorities and attendance at events for school
representatives.
Where schools decide to participate in the trial they
will agree to offer the MT programme as part of the
standard school curriculum. That is to say parental opt-
out and child assent relates to the research (baseline and
full RCT assessments) and not the MT or TAU. Consent
to participation in MT or TAU curricula is at school
level. Schools in the MT arm will be free to teach the
MT programme to nontrial classes as they wish, but we
will not collect data from these pupils.
Randomisation procedure
Schools (clusters) will be randomised using computer-
generated random numbers by an independent statisti-
cian. The schools will be assigned unique study numbers
so their identities are unknown to the statistician, thus
ensuring allocation concealment. The schools in each
cohort will ideally be randomised as a single batch. The
following are a selection of the variables that will be
considered for stratifying the randomisation, with final
decisions taken once schools have been recruited in each
cohort: school size (large/small), type and quality of
school (selective/nonselective, independent/nonindepen-
dent, mixed/single-gender, school-quality measure, e.g.
OFSTED), geographic location (urban/rural and region)
and level of deprivation (e.g. below or above median of
children eligible for free school meals).
Participating children will normally be recruited from
the schools in the autumn term of the school recruit-
ment years (September through December) [82].
Interventions
The MT programme and TAU will be delivered at
school (cluster) level. Both will be mapped as far as pos-
sible using a template for intervention description and
replication (TIDieR) checklist and guide for reporting
complex interventions [83]. UK schools deliver social-
emotional teaching in different ways and will likewise
choose to integrate MT within their existing provision in
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different ways. Thus, the trial cannot be categorised as
either purely additive (MT in addition to existing social-
emotional teaching provision) or substitutive (MT re-
placing existing social-emotional teaching provision) in
its design. Rather, different schools will be at different
points on this hypothetical continuum and we will re-
port details of provision of social-emotional teaching in
schools across both arms of the trial, collected through a
bespoke measure administered by the research team to
one or more relevant staff members within each school
and supplemented by review of school policy documents
and other relevant materials.
MT programme [63]
The MT goals are to enable adolescents to learn mind-
fulness skills that enhance mental regulation and execu-
tive control across the spectrum of risk/resilience. The
MT programme is drawn primarily from MBCT [52]. A
unique feature of the MT programme is its focus on the
full spectrum of functioning from mental health prob-
lems to flourishing, enabling all young people to use
mindfulness skills to manage emotions, academic study,
sport, sleep and relationships. It was developed over
more than 5 years by three classroom teachers (Richard
Burnett, Chris Cullen and Chris O’Neill) who are also
experienced mindfulness practitioners. This has included
ensuring that the programme can be taught in main-
stream schools, how best to engage hard-to-reach chil-
dren and how to manage challenging classroom
behaviour. It has been developed and adapted to ensure
that it is acceptable to diverse school contexts and stu-
dent populations. Latterly, the programme has been en-
hanced to support children to practice mindfulness
during and beyond the course.
The MT programme comprises several elements, de-
livered through the school curriculum, over several
years, supported by teacher training. The bulk of the
MT programme is taught to students in a set of 10
structured lessons (within the trial, taught in years 8
and/or 9). The MT programme will normally be deliv-
ered in the spring terms (January through April), with
support to continue use of mindfulness skills into the
summer term. In the following school years, there are
follow-on lessons intended to continue and support fur-
ther learning and ongoing mindfulness practice (e.g.
lunchtime clubs or drop-in sessions). This follow-on
training in subsequent school years aims to sustain,
deepen and begin to apply students’ learning; for ex-
ample, to managing tests and examinations and to
embed mindfulness in the school ecology/climate.
The MT programme includes a combination of
psycho-education and practical skills involved in training
the mind, learned in an experiential way, through short
mindfulness practices which focus on the breath, body
and immediate experience. There is also classroom dis-
cussion of the application of new skills in everyday life.
Its design aligns with principles identified as important
for effectiveness in several reviews of schools-based pro-
grammes that promote mental health and wellbeing and
teach social and emotional competence. These principles
include: explicitly teaching skills and attitudes; tailoring
components and approaches to the needs of young
people; using a range of age-appropriate, interactive,
experiential and lively teaching methods; providing age-
appropriate resources; for example, in this context re-
sources that bring mindfulness to life (including a course
booklet, a set of mindfulness exercises provided online
and mindfulness practices that are introduced through
animations and available as digital downloads); intensive,
focussed teacher education to build teachers’ self-efficacy
and wellbeing; and programme implementation which
pays close attention to clarity and fidelity, in this case
supported by a manual and indicative script [19, 21, 58].
Building on data that greater practice is associated with
better outcomes [84, 85], the MT programme includes
strategies to support teachers in keeping mindfulness in-
tegral to the culture of their year group/the school as a
whole. Examples of good practice in this area could in-
clude teacher catch-up days/support events, suggested
schedules for progressive, regular mindfulness input
throughout year groups, suggested smartphone apps and
using parts of the MT programme in core curriculum
subjects.
Whilst all participating schools randomised to MT will
have agreed to deliver the MT programme to a mini-
mum of three classes within years 8 and/or 9, they will
be encouraged to consider how they might introduce
mindfulness into the curriculum more broadly, for the
potential benefit of other school pupils and the wider
school climate.
Because implementation affects both reach and out-
comes [86], all schools will be supported with imple-
mentation guidance to increase the likelihood that MT
is introduced into the schools in ways that maintain its
integrity and are sustainable. For example, implementa-
tion of MT will require engagement with school leader-
ship teams, teachers and pupils, as identified; for
example, in research in disadvantaged urban schools in
the US [77, 87].
Training teachers to deliver the MT programme
The training programme to deliver the MT programme
involves teachers first participating in an 8-week MBCT
programme, adapted for the general (nonclinical) popu-
lation, to support the development of their resilience
and mindfulness skills (eight 2-h sessions per week, with
an all-day mindfulness session supported by a digital app
to facilitate mindfulness practice during and after the 8-
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week course). They will then attend a 4-day training
workshop to learn how to deliver the MT in schools,
with support where needed when they move onto teach
themselves. Within participating schools, as large a pool
of teachers as possible will be trained to build in redun-
dancy should teachers either not achieve required levels
of competency or leave the school. Training a larger
group of teachers will also support greater implementa-
tion of the MT programme within the school, outside
trial classes, as well as offering peer support throughout
the project.
Fidelity of the MT programme
To test the effectiveness of the MT programme we need
to ensure that it is delivered with fidelity. The teacher
training and MT programmes are highly structured and
standardised to maximise fidelity. Through teacher se-
lection and teacher training we will endeavour, as far as
possible, to ensure that teachers reach an adequate
standard before they teach trial classes. During the trial
classes, competency/adherence will be monitored. Inde-
pendent raters will rate a randomly selected subset of
videotapes of MT programme classes for fidelity (adher-
ence and competence) using a standardised measure de-
veloped by the study team with adaptations made for
MT in schools [88, 89].
Teaching as usual in line with good practice
The trial aim is to establish if MT, when integrated into
social-emotional teaching in secondary schools, adds
value over and above current good practice. Recent UK
Department of Education reports suggest that 60% of
secondary schools offer Personal, Social, Health and
Economic Education (PSHE) lessons that are ‘good or
better’ and that this provision occurs across ages 11–16
years (Key Stages 3 and 4) through a variety of methods
including regular scheduled lessons, drop-down days,
within other subjects, and in tutor/form time [17, 90].
Determining whether schools have good PSHE provision
is challenging. In cohort 1, schools will be eligible for in-
clusion if their provision of PSHE (or equivalent) meets
four criteria: (1) the presence of discrete, regular, named
teaching time for PSHE, (2) a named PSHE lead, (3) a
written PSHE policy and (4) a named member of the se-
nior leadership team responsible for PSHE. TAU schools
will agree not to provide the MT programme (or other
curricula that include MT) until study completion. We
will conduct a more detailed enquiry into the provision
of PSHE in general and social and emotional learning
(SEL) elements, in particular at each of the cohort-1
schools (see below), and will use the findings of this to
describe provision and modify inclusion criteria for co-
hort 2 if required. This approach ensures that MT’s ef-
fectiveness is tested against current good practice.
PSHE/social-emotional teaching as usual in both trial arms
Following randomisation, the current provision of
social-emotional teaching will be explored using a be-
spoke tool developed for the MYRIAD trial drawing in
part on existing measures [17]. This will enable us to re-
port upon how schools describe their current practice
with respect to PSHE in general, and social-emotional
teaching in particular, in all randomised schools at the
school level and for study pupils within each school and
across both trial arms. It will further provide information
on how the MT curriculum is integrated into wider
teaching provision in intervention schools. This measure
will be used initially in cohort 1 and both it, and the ini-
tial PSHE eligibility criteria, will be modified if necessary
for subsequent cohorts.
Baseline assessment and follow-ups
Study outcomes will be measured at school consent/
baseline (prior to randomisation1), preintervention
(school term before intervention begins or equivalent),
post intervention (within 3 months of the end of the
MT programme or equivalent time in the TAU arm), 1-
year follow-up (1 year after preintervention measures)
and again at 2-year follow-up (2 years after preinterven-
tion measures, see Fig. 2). The data gathered from study
participants and other sources at each time point are
shown in Fig. 2.
Sample size
The study requires 76 schools in total. All year-7 and
year-8 pupils in each participating school (approximately
25,000 in total) will be invited to take part in a baseline
assessment. In the subsequent academic year pupils who
are members of three or more randomly selected classes
(approximately 90 pupils in total per school) will be eli-
gible to participate in the full trial. Thus, approximately
6840 pupils will be eligible to participate in the full trial
with the expectation that 5700 will have provided paren-
tal consent/pupil assent and 4560 will ultimately
complete the trial at 2-year follow-up. Drawing on the
two feasibility studies [66, 72], a conservative assump-
tion is made that in each class of 30, 25 children will
have consent/assent to participate, and 20 of these will
be followed up over 2 years. However, because parental
opt-out consent and pupil assent will have been obtained
prior to trial class selection where levels of consent/
assent are lower than expected, we will have the flexibil-
ity to include more classes within a school in order to
ensure that the required number of participants (75 in
each school) proceed to full trial participation. The 38
schools (clusters) and 2280 children in each trial arm at
follow-up (76 schools and 4560 children altogether) is a
large enough sample to detect a difference of 0.2 stand-
ard deviation units (effect size) on our continuous co-
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primary outcomes. The sample size has been inflated to
allow for multiple testing, setting the two-tailed signifi-
cance level (alpha) for comparing each individual out-
come between the trial arms to 0.0167 to preserve the
overall family wide Type I error rate at 0.05. The study
has 90% power to detect the specified effect size for each
co-primary outcome as statistically significant. The sam-
ple size also allows for: (1) clustering of outcomes within
schools, assuming an intracluster (intraschool) correl-
ation coefficient (ICC) of 0.04, and (2) 20% dropout,
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) diagram detailing trial activities and measures and their timing
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with 60 of the 75 children consenting to participate in
the trial providing full follow-up data within each school.
Relevant literature suggests that our assumed value of
the ICC is conservative. The largest ICC in one of our
feasibility studies [66] was 0.037. The ICC for the same
measure of depression as used here (CES-D) has been
estimated to be 0.033 from a previous study in Quebec
based on around 5000 children from across 71 schools
drawn from relatively disadvantaged communities [91]
and to be 0.009, 0.015 and 0.017 for different year levels
(year 8, year 9 and year 10, respectively) based on
around 2500 children from across 25 state-funded
schools in South Australia spanning the full socioeco-
nomic spectrum [92].
Outcome measures
Multimethod and multi-informant measures will be used
that have reliability, validity and established sensitivity to
change, balanced with consideration to minimising bur-
den on both participants and researchers and maximis-
ing data quality. All measures will be completed either
on paper or via an online system. The pupils will
complete the measures in a classroom setting where
possible. Details of the measures and the time points at
which they are collected are shown in Fig. 2. Where pu-
pils are absent from school on the day at which data are
obtained we will liaise with relevant school personnel to
determine the most appropriate way of gathering these
data, and will endeavour to gather data from as many
absent pupils as possible to maximise data completeness.
Primary outcomes (pupil completed)
Our aim is to determine the effectiveness of the MT
programme based on three co-primary outcomes at 2-year
follow-up: risk for depression (Center for Epidemiologic
Studies for Depression Scale; CES-D; [64]); social/emo-
tional/behavioural functioning (Strengths and Difficulties
Questionnaire, youth version; SDQ [93]); and wellbeing
(Warwick-Edinburgh Mental Wellbeing Scale; WEMWBS
[65]). There was consideration of selecting just one
primary outcome but the research team, experts in
the field who were consulted and peer review con-
cluded that all three co-primary outcomes are critic-
ally important. The research team also considered
combining the three co-primaries into a composite
outcome. However, as the research question includes
the specific effect of the intervention on each of the
three aspects, not just the overall effect, it was de-
cided to retain the primary outcomes in their natural
form. Composite measures can obscure variation that
would convey interesting and important information
in our proposed work [94].
There are a number of reasons for the choice of pri-
mary outcomes. First, adult depression (like mental
health generally) is predicted by a range of difficulties in
adolescence, including not only low-grade depressive
symptomatology, but also social/emotional/behavioural
functioning [13, 95–97]. Second, MT is a complex inter-
vention that is specifically designed for young people
along the full spectrum of risk/resilience and mental
health. The outcome measures, therefore, needed to as-
sess both problems (e.g. depressive symptoms) and also
positive mental health. In such instances, and in line
with the Medical Research Council (MRC) Complex In-
terventions Framework [98] and evolving guidance in
the literature [99, 100], a number of critical outcomes
were chosen as co-primary outcomes that: (1) are tar-
geted by MT, (2) cover the full spectrum of mental
health risk/resilience and (3) predict later psychopath-
ology/mental health.
Secondary outcomes (pupil-, teacher- and school-based)
A range of individual-level secondary outcome measures
have been chosen based on their value to education
policy-makers, school heads and pupils themselves. Sec-
ondary outcomes are:
 Students’ executive functioning (Behaviour Rating
Inventory of Executive Function, self- and teacher-
rated versions; BRIEF-2 [101])
 Peer relationships (Resistance to Peer Influence
Scale [102])
 Drug and alcohol use, assessed using a brief measure
designed for the study
 Anxiety (anxiety subscales from the Revised Child
Anxiety and Depression Scale; RCADS [103])
 Social, emotional and behavioural functioning
(Strengths and Difficulties Questionnaire, teacher
version [93])
 Student-level attainment (National Pupil Database
[104, 105])
 Self-harm and suicidal ideation (measured devised
for study)
 Mindfulness skills (Child-Adolescent Mindfulness
Measure; CAMM [106])
To support resource allocation decision-making and
guideline development by bodies, such as NICE [107],
the EuroQol five dimensions measure of health-related
quality of life, youth version (EQ-5D-Y) [108], suitable
for the calculation of Quality-adjusted Life Years
(QALYs) and application to economic evaluation, will
also be included, alongside the Child and Adolescent
Service Use Schedule (CA-SUS).
Given the high rates of teacher stress and burnout, the
importance of school ecology/climate, and the potential
of MT to address these variables, the following will also
be secondary outcomes:
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 Teachers’ wellbeing (Maslach Burnout Inventory,
Educator Survey; MBI [109])
 Self-efficacy (Teacher’s Self-efficacy Scale; TSES
[110])
 Personal mindfulness (Five Facet Mindfulness
Questionnaire, short form; FFMQ-SF, [111])
 Teacher mindfulness (Mindfulness in Teaching
Scale; MTS, [112])
 Stress (Perceived Stress Scale; PSS [113]),
 Depression (Patient Health Questionnaire; PHQ9
[114])
 Anxiety (Generalised Anxiety Disorder; GAD7
[115])
Teacher-level variables will be measured for those
teachers within schools identified to teach the interven-
tion prerandomisation, irrespective of which arm of the
trial their school is subsequently randomised to. School
(cluster)-level outcomes will include school ecology/cli-
mate (subscales most relevant to the intervention from
the School Climate and Connectedness Survey (SCCS)
[116]) and school-level attainment; for example, GSCE
results (National Pupil Database).
Study outcomes will be measured at five time
points: baseline (school and teacher as well as pri-
mary measures for all pupils from years 7 and 8);
preintervention (school term before intervention or
equivalent); 3 months post intervention (or equiva-
lent); 1 year (1 year after preintervention) follow-up;
and again at 2-year follow-up (2 years after preinter-
vention). It is important that outcomes are measured
over a short enough period to enhance data com-
pleteness as well as over a long enough period to
examine emergent risk/resilience over time.
Economic data
The economic evaluation will take a health and social
care perspective, as preferred by NICE [107], but will
additionally include education-based services, since evi-
dence suggests that health and education make up the
majority of the costs of caring for young people with
depression [117].
Service use will be recorded using a brief version of
the Child and Adolescent Service Use Schedule (CA-
SUS), successfully applied in previous adolescent depres-
sion populations [117]. A brief version focussing on key
services (high cost and high volume of use), suitable for
self-completion by parents of primary school children, is
currently being applied in a similar school-based cluster
RCT [73]. This measure will be adapted for application
to an older population and for self-completion by the
young people. Economic data will be collected at pre
and post intervention as well as at 1- and 2-year follow-
up. The preintervention measure will collect information
covering the previous 3 months; at follow-up the service
use will be recorded for the period since the most recent
prior assessment of this data .
Resource inputs into MT training and delivery will be
recorded as part of the trial and will be costed using a
micro-costing approach. This will involve calculation of
the cost of all individual elements (teaching and training
staff time, any supply teaching expenses, training and
intervention materials, etc.), as well as relevant over-
heads (administration, managerial, capital, etc.) and ad-
justment for indirect time (non-face-to-face working
time which cannot easily be allocated to specific individ-
uals). All other services used will be costed by applying
nationally applicable unit costs, including National
Health Service reference costs for secondary care ser-
vices, as well as published costs for primary care, social
care and education services [118].
Outcomes for the economic evaluation will be mea-
sured using the youth version of the EQ-5D measure
of health-related quality of life (EQ-5D-Y) [108],
shown to be valid and responsive to change in ado-
lescent populations [119].
Analysis plan
Analyses will be conducted/supervised by the co-
investigator trial statistician (Obioha Ukoumunne) and
trial health economist (Sarah Byford) and reported fol-
lowing CONSORT standards, overseen by the Data
Monitoring Committee (DMC) and documented in a full
prespecified statistical analysis plan. Analyses will be
conducted on an intention-to-treat basis, with partici-
pants analysed according to the trial arm that they were
randomised to, using multiple imputation to ‘fill in’
missing data. Comparisons will also be made between
the trial arms, based on those with complete data in a
sensitivity analysis. All between-arm comparisons will be
run first as crude (unadjusted) analyses and then ad-
justed for baseline prognostic factors, chosen a priori,
but certainly including the factors used to stratify the
randomisation and, where measured, the baseline score
of the outcome variable. The adjusted analysis will be
considered to be the main analysis.
The approach to evaluating the intervention empha-
sises estimation of the intervention effect (confidence in-
tervals), rather than strictly hypothesis testing. In
recognition of the multiple testing, we will use an ad-
justed critical level for significance testing of 0.0167 for
each of the three primary outcomes at 2 years to main-
tain the overall Type I error rate at 0.05. The confidence
intervals will not be adjusted for multiple comparisons.
No adjustments will be made to the critical levels for
testing the primary outcomes at the earlier follow-ups,
nor the secondary outcomes, as these are more explora-
tory in nature. The study sets out to establish the
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superior effectiveness and cost-effectiveness of MT com-
pared with TAU. As set out above, all the co-primary
outcomes are deemed important in their own right, such
that each will be reported independently.
The main reported clinical analysis will use the
intention-to-treat principle. The definition of a trial par-
ticipant will be those who provide data at the baseline
assessment and are subsequently in the classes randomly
selected for participation in the full trial. In ancillary ex-
ploratory analyses we will also examine whether the ef-
fectiveness of the intervention is greater for schools,
teachers and pupils that adhere to the curriculum (i.e.
engage with intervention and, in the case of pupils in
the MT arm, use the mindfulness practices). Because ad-
herence is likely to be associated with factors that impact
on the outcomes, we will account for this confounding
using instrumental variable methods [120].
All analyses will account for clustering within schools
as this is a cluster-randomised design. Continuous out-
comes will be compared using random effects (‘multi-
level‘) linear regression and binary outcomes will be
compared using marginal logistic regression models
using Generalised Estimating Equations (GEEs) with in-
formation sandwich (‘robust’) estimates of standard
error, specifying an exchangeable correlation structure
within clusters. Continuous outcomes will be sum-
marised for each trial arm using means and standard de-
viations and binary outcomes will be summarised for
each trial arm using numbers and percentages.
We will use tests of interaction to explore potential
moderators of outcome, including, but not exclusive to:
school level deprivation (proportion of pupils eligible for
free school meals); the children’s age/year group; base-
line risk for depression; wellbeing; and strengths and dif-
ficulties (SDQ). The latter is particularly important, as it
is key to engagement with MT. These analyses are ex-
ploratory and hypothesis-generating in nature [121]. We
acknowledge the issue of multiple testing and the need
to cautiously interpret significant findings that will re-
quire replication in subsequent studies to have credence.
We also acknowledge the low statistical power of tests
of interaction in comparison to the power for detecting
main effects [122].
Whilst mechanisms of action and potential mediators
are examined in detail in a separate programme of work,
we will explore potential mechanism variables pre and
post MT in both trial arms and key outcomes at 1- and
2-year follow-up. We will ask if the change in mecha-
nisms is specific to MT, changes as a function of use of
mindfulness skills, precedes changes in the outcomes,
and explains changes in key outcomes at follow-up. We
will examine whether such changes occur over and
above changes in those outcomes from baseline to post
treatment [123] and through moderated mediation
explore what works for whom. Methods for the analysis
of mediation using clustered data are in the infancy of
their development [124]. We will keep abreast of on-
going methodological research in this area and these
analyses will be both exploratory and hypothesis-
generating in nature.
Cost-effectiveness will be assessed in terms of QALYs
using the EQ-5D-Y. Secondary analyses will explore
cost-effectiveness in terms of the three co-primary out-
comes to assess the sensitivity of analyses to the alterna-
tive outcomes of interest. We will employ standard
methods of analysis, including multiple imputation for
missing data, adjustment for baseline prognostic factors
in line with the clinical analyses, and standard paramet-
ric tests for differences in costs, with the robustness of
the parametric tests confirmed using bias-corrected,
nonparametric bootstrapping [125]. Cost-effectiveness
will be assessed using the net benefit approach, with un-
certainty explored through the presentation of cost-
effectiveness acceptability curves [126]. A within-trial
analysis will be undertaken at 2-year follow-up.
The lifestyle choices and behaviour of young people
on the threshold of adulthood can lead to short- and
long-term adverse outcomes that are expensive for soci-
ety and damaging to themselves [127, 128]. To this end,
longer-term outcomes and costs will be explored using
decision analytic modelling [129]. The model will be
populated using data from our ongoing programme of
work, including trial data and research on teacher train-
ing models, as well as evidence from the literature and
relevant longitudinal cohort databases. The most suit-
able modelling framework in which to carry out the ana-
lysis will be dependent upon the results of the RCT, and
thus will be finalised at a later point. Markov modelling
is likely to be the most appropriate for extrapolation
over the longer term since it is able to deal with rela-
tively complex care pathways. The cost-effectiveness
model will be analysed using incremental analysis and
probabilistic sensitivity analysis. The time period over
which the model will be run will be determined after re-
view of the literature, since data availability is the key
limiting factor. These analyses are exploratory and
hypothesis-generating in nature [121].
Minimising bias
To maximise generalisability, we will actively recruit
schools that are representative of the UK population,
with particular, but not exclusive, attention to key vari-
ables, such as deprivation, operationalised as eligibility
for free school meals and region and the type of school
(e.g. selective/nonselective, urban/rural, large/small,
mixed/single-gender, state maintained/independent). As
recruitment progresses we will, as far as possible, moni-
tor recruited schools and teaching staff within these
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schools in terms of their match to these variables, ac-
tively seeking schools with characteristics that will im-
prove the representativeness of the sample. In the event
that we have more interested schools than we are able to
recruit, we will make decisions on suitability based partly
on the intention of achieving a representative sample of
schools.
To minimise contamination across clusters we will ran-
domise at the level of school, and secure schools’ agree-
ment to adhere to the regime of the trial arm to which
they are allocated. Attrition bias will be minimised by
building on robust trial procedures developed in our feasi-
bility trials [66, 130]. Retention of pupils is predicted to be
80% at follow-up. We have demonstrated that we can
achieve close to 97% data from pupils and 100% retention
of schools/teachers completion in our feasibility studies,
albeit it with shorter follow-ups [66, 130]. As randomisa-
tion is at the level of school, if teachers leave, provision
can be made within schools for cover by allocating an-
other teacher able to offer the interventions. We will ex-
clude schools from the study with an inadequate school
quality rating or without a substantive head because of the
risk to implementation. Trial newsletters and social net-
working will be used as a way of keeping in touch with
schools and participants between follow-up points.
Robust randomisation procedures conducted by an in-
dependent statistician and prepublication of the trial
protocol, and subsequently the data analysis plan, will
minimise subversion bias. To limit potential for bias
when unblinded researchers are involved in collection of
self-report data from pupils, all researchers will be
trained to introduce the study and measures in a stand-
ard way and provide standard responses to queries about
the interpretation of questionnaire items.
Blinding of data files
The trial data file will be cleaned, locked and signed-off
by the Trial Steering and Data Monitoring Committees
before the trial statistician is unblinded. The remainder
of the trial team will only have access to the unblinded
data file following completion of main trial data analyses
and presentation of main trial outcomes. Co-
investigators other than Professor Willem Kuyken will
remain blind to which trial arm each individual school is
randomised as far as possible. Other members of the re-
search team will be aware of school trial arm to facilitate
implementation of the protocol within trial schools.
To maximise data completeness, data will be collected
either through an online portal using tablets/laptops or
through paper and pencil measures, whichever is pre-
ferred by the school/teacher/pupil. Pupils who are absent
from school will normally be contacted through their
school. In cases where pupils or teachers leave the
schools, attempts will be made to follow them up to
complete remaining measures. Teachers will be remu-
nerated for completion of student-focussed measures.
Time windows for the follow-up assessments will be
large enough to maximise data completeness.
Data management and integrity will be maximised by
using protocols established in our previous trials includ-
ing using online data entry and, where appropriate,
through double entry. All data will be stored securely in
line with our data management protocol in order to pro-
tect the confidentiality of participants. Finally, analytical
biases will be minimised by prepublishing the study
protocol prior to randomisation and the statistical ana-
lysis plan prior to analysis.
Measurement of preference
In line with guidance for the design of RCTs [131], we
will write our study materials to ensure that they provide
clear information about the two trial arms. We will as-
sess headteachers’ preferences at baseline.
Trial governance
The management structure will ensure that the scientific
aims are delivered and provide robust governance and
oversight. Oxford University will sponsor and host the
study and we sought ethics approval from the University
of Oxford Central Research Ethics Committee.
A Trial Management Group (TMG) comprising the co-
investigators and trial manager will provide day-to-day
management of the project. TMG meetings will review
progress against study milestones, plan work, discuss
methods, keep a risk register and anticipate/resolve any
problems. The first meeting will be face-to-face and then
via video/teleconferencing throughout the project, with
face-to-face meetings at least once a year. They will seek
input from collaborators and others, as needed.
A Trial Steering Committee (TSC) and Data Monitor-
ing Committee (DMC) will be established to provide
trial oversight. They will be independent of the study
team and trial sponsor and free of competing interests.
The committees will be chaired and constituted by
people with the requisite specialist expertise and experi-
ence. Copies of the TSC and DMC charters can be ob-
tained from the authors on request. The Peninsula
Clinical Trials Unit will support the trial in terms of
database development, randomisation, and data
management.
Ethics
The investigator will ensure that this study is conducted
in accordance with the principles of the Declaration of
Helsinki. Ethics procedures build on our feasibility trials
and other schools-based trials [73]. We will ensure con-
sent at the school level from headteachers. We will then
seek parental/caregiver opt-out and child assent.
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Consent from headteachers will be obtained electronic-
ally following detailed discussions between the headtea-
cher or their representative and the research team.
Consent from teachers will also be obtained electronic-
ally following a similar process. Parental opt-out consent
will be managed by schools using ethically approved par-
ent/carer and Pupil Information Sheets and an Opt-out
Form and adopting the methods usually employed by
the school for obtaining parental consent (e.g. electronic,
hard copy or both). Pupils will provide assent at the start
of the baseline assessment, through the computer termi-
nals on which they will subsequently complete study
measures, or occasionally, on paper. Cluster RCTs
present particular ethical issues and we will, therefore,
follow the Ottawa Group 15 consensus recommenda-
tions for cluster RCTs, with school headteachers identi-
fied as the ‘gatekeepers’ [79]. Child welfare and
safeguarding procedures have been developed with input
through our stakeholders (headteachers, teachers and
young people). The investigators will ensure that this
study is conducted in accordance with relevant regula-
tions and with Good Clinical Practice. Researchers who
will be obtaining informed consent will complete rele-
vant components of Good Clinical Practice training. All
members of the research team will undergo clearance
through the UK disclosure and barring service. The
study has received approval from the University of Ox-
ford Central University Research Ethics Committee
(CUREC). Any substantial change to the protocol design
that alters the ethical frame of the project will be sent to
the Ethical Committee for further review and any
changes made as a result of this would be reported to
the ISRCTN Registry. A random sample of approved
CUREC projects may be monitored each year by the
relevant CUREC subcommittee to review whether the
research is being (or was) conducted within the scope of
the ethical approval granted.
The recruitment and research governance procedures
developed in the STARS (Supporting Teachers And chil-
dRen in Schools) trial [73] and our feasibility study will
be used [66]. Our feasibility study did not identify any
risks to young people arising from the research proce-
dures or MT itself. However, a risk management proto-
col has been developed to provide a consistent approach
to the identification and reporting of risk. This protocol
will be discussed and agreed with the headteachers/safe-
guarding leads at each participating school and builds on
the protocol developed in our earlier trials. The protocol
will ensure that, where young people are identified as at
risk of abuse, appropriate safeguards are put in place in
a timely way. Young people who disclose concerns dir-
ectly to the research team in person, or via another
means of direct communication rather than through
Case Report Forms, will be followed up to ensure that
they receive appropriate support. All young people will
be provided with bespoke information on local and na-
tional sources of support, the content of which will be
agreed with participating schools. Likewise, participating
teachers who are identified as at risk of harm will be
followed up in accordance with the protocol for risk
management. Data on serious adverse events (death,
overnight hospitalisation, prolongation of existing hospi-
talisation, persistent or significant disability/incapacity,
life-threatening situations and attendance at accident
and emergency departments) will be collected as the re-
search team becomes aware of them both as they arise
and as part of routine data collection at each assessment
point and will be reported to the DMEC within 7 days
of the research team becoming aware of them. Adverse
events will be logged and reported via the DMEC and
TSC, and the DMEC will review aggregate data on child
mental health and self-harm outcomes to ensure that
there is no excess of such outcomes in the active arm.
As we are collecting data in two cohorts, the end of the
first cohort provides an opportunity for the DMEC and
TSC to review these data and the robustness of these
procedures once the first wave of intervention has been
completed.
Dissemination of outcomes
We are committed to maximising dissemination of
knowledge arising from the MYRIAD trial and making
the outputs of this work available to the widest possible
audience. We will achieve this through the open access
publication of research findings in high-quality peer re-
view journals and through the appropriate presentation
of the research at conferences and meetings. We will
also endeavour to make our research directly available to
relevant communities and groups, such as schools,
teachers and young people, in an accessible format
through a programme of public engagement activities
planned in collaboration with our public engagement
group. Details of plans for dissemination and authorship
eligibility guidelines are outlined in the MYRIAD dis-
semination protocol v6, 14.11.15.
Discussion
This cluster RCT aims to provide a rigorous evaluation
of the effectiveness and cost-effectiveness of a MT
programme, compared with good practice teaching of
social-emotional curricula, for young people aged 12–14
years within secondary schools. It will answer a question
with significant public health implications; namely ‘can a
universal school-based intervention, in this case MT,
shift the population away from mental ill-health and to-
wards improved mental health and wellbeing?’
If the trial suggests that MT is cost-effective, this could
enable schools to offer a relatively low-cost, scalable
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intervention to improve young people’s short- and
longer-term social, emotional and mental health out-
comes. This would have implications in terms of pre-
venting mental health problems before they can take
root and become a lifelong recurring problem. More-
over, there are prospective studies suggesting that the
executive control skills MT seeks to develop are associ-
ated with a range of long-term health, social and eco-
nomic outcomes [37]. This study will examine whether
integrating MT into social-emotional teaching as usual,
when compared with continuing social-emotional teach-
ing alone, positively affects these pupil outcomes at 2-
year follow-up. To assess longer-term outcomes we plan
to establish a cohort, to follow participants up into
adulthood, linked to the National Pupil Database. There
are also significant potential benefits for schools in terms
of teacher mental health, wellbeing and functioning and
school ecology/culture. Finally, alongside our other pro-
grammatic work, the trial will contribute to our under-
standing of for whom, and when, MT is best delivered,
its mechanism of action, and the most scalable approach
to training teachers to deliver the MT programme.
Trial status
Recruitment of schools began in late June 2016, with re-
cruitment of pupils beginning in September 2016. Ran-
domisation for schools in cohort 1 will occur in
December/January 2016–2017. Recruitment for cohort 2
will begin in January 2017 and continue throughout the
year with randomisation for cohort 2 planned for
December/January 2017–2018.
Endnotes
1For pragmatic reasons at this time point only the pri-
mary outcome measures for the pupils will be measured.
Additional file
Additional file 1: Completed SPIRIT 2013 Checklist for the MYRIAD Trial.
(DOC 121 kb)
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